title: 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
abstract: Prompted by the report of a mitochondrial myopathy associated with chronic administration of zidovudine (AZT), an inhibitor of mitochondrial DNA synthesis, we obtained 31P magnetic resonance spectra from the calf muscles of AZT-treated patients and age-matched control subjects at rest and during an exercise protocol with a 12-second time resolution. The recovery of phosphocreatine following exercise reflects mitochondrial oxidative function and was significantly delayed in the AZT-treated patients (time constants, 43.3 +/- 12.5 seconds versus control subjects, 24.4 +/- 3.9 seconds). These findings support the hypothesis that the myopathy associated with chronic AZT results from the inhibitory effects of AZT on mitochondrial DNA synthesis and, secondarily, on the inhibition of mitochondrial oxidative metabolism.
authors.affiliation: Department of Neurology, Emory University, Atlanta, GA.
authors.forename: J D
authors.initials: JD
authors.lastname: Weissman
authors.forename: I
authors.initials: I
authors.lastname: Constantinitis
authors.forename: P
authors.initials: P
authors.lastname: Hudgins
authors.forename: D C
authors.initials: DC
authors.lastname: Wallace
mesh_terms: D000328:Adult; D015444:Exercise; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008297:Male; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000473:pathology*; D009135:Muscular Diseases / Q000139:chemically induced / Q000473:pathology; D010725:Phosphocreatine / Q000378:metabolism; D015215:Zidovudine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D010725:Phosphocreatine; D015215:Zidovudine